the aid library

LIST OPTIONS

Filter

5704

Laboratory techniques in rabies Fifth edition Volume 2

Rupprecht, C.; Fooks, A.; Abela-Ridder, B. World Health Organization WHO (2019) C_WHO

Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ... more

Download (285)

View PDF (346)

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations

World Health Organisation (WHO) (2023) C_WHO

The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations. It covers the following items: Global Reports Immunization Agenda 2030 and Regional reports Monkeypox RSV COVID-19 vacci... more

Download (239)

View PDF (249)

COVID Reference 2020.4 POR

Kamps, B.S.; and C. Hoffmann (2019) CC

4ª edição Nos próximos meses, a COVID Reference apresentará atualizações regulares e narrará os dados científicos o mais coerente possível.

Download (291)

View PDF (414)

Situational Brief: Impact of Covid-19 on forcibly displaced persons inside Syria

Marzouk M., Rayes D., Y. Douedari et al. Lancet Migration (2020) CC

Over nine years of protracted and violent conflict in Syria has decimated its health system,killed an estimated 586,000 people and forcibly displaced more than half the 22 million pre-war population from their homes. As of June 2020, a total of 6.2 million Syrians (of whom 40% are children) are inte... more

Download (202)

View PDF (493)

COVID-19 health system response monitor, Thailand

World Health Organization. Regional Office for South-East Asia (2020) C_WHO

Download (237)

View PDF (440)

Job satisfaction among healthcare workers in Ghana and Kenya during the COVID-19 pandemic: Role of perceived preparedness, stress, and burnout

Afulani PA, Nutor JJ, Agbadi P, Gyamerah AO, Musana J, Aborigo RA, et al. PLOS Global Public Health (2021) CC

The COVID-19 pandemic has affected job satisfaction among healthcare workers; yet this has not been empirically examined in sub-Saharan Africa (SSA). We addressed this gap by examining job satisfaction and associated factors among healthcare workers in Ghana and Kenya during the COVID-19 pandemic. W... more

Download (633)

View PDF (1031)

South-East Asia regional vaccine action plan 2016-2020

World Health Organization (WHO), Regional Office for South-East Asia (2018) C_WHO

The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of... more

Download (498)

View PDF (748)

Sierra Leone: Health Sector Annual Operational Plan (AOP) 2016/17

Government of Sierra Leone, Ministry of Health and Sanitation (2016) C1

Download (859)

View PDF (1832)

Rapid assessment of Ebola impact on reproductive health services and service seeking behaviour in Sierra Leone

Government of Sierra Leone, Department for International Development, UN Population Fund, Irish Aid (2015)

Download (1535)

View PDF (2891)

WASH Package for Ebola Care and Treatment Centres/Units

UNICEF (2014)

Guidance Note. The recommended actions are presented under the different components (water supply, hygiene and hand washing, disinfection, solid waste management, latrine and wastewater management, and dead body management) of the defined Ebola Care Centre/Unit WASH package to complement community a... more

Download (294)

View PDF (311)

CH 5: Effective strategies for detecting maltreatment of children and youth within the context of mental health and developmental assessment.

World Health Organization (2015) C_WHO

(New 2015) Scoping question: Within the context of mental health and developmental assessment of children and youth, what are the effective strategies for detecting maltreatment?

Download (2026)

View PDF (3991)

Dengue, Dengue Haemorrhagic Fever and Dengue Shock Syndrome in the Context of the Integrated Management of Childhood Illness

World Health Organization (2005) C_WHO

Download (1018)

View PDF (1406)

Implementation of Early Warning and Response with a focus on Event-Based Surveillance

World Health Organization (2014) CC

Early detection, assessment and response to acute public health events:

External Link

Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC

Centers for Disease Control and Prevention; Department of health and human services Morbidity and Mortality Weekly Report (2006) C_CDC

Morbidity and Mortality Weekly Report Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9

Download (449)

View PDF (701)

Framework of Indicators and Targets for laboratory strengthening under the end tb strategy

World Health Organization (2016) C_WHO

Download (501)

View PDF (706)

Operational Guide: The Early Warning and Response System (EWARS) for Dengue Outbreaks

World Health Organization WHO; TDR Program (2018) C_WHO

This guide is a revised edition to the previous version published in 2017. This updated publication provides programme managers with a user-friendly tool that can: (i) analyse and draw conclusions from historic dengue datasets; (ii) identify appropriate alarm indicators that can predict forthcoming... more

External Link

A double dose of inequality; Pharma companies and the Covid-19 vaccines crisis

Amnesty International (2022) C2

22 Sept. 2021 The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi... more

Download (268)

View PDF (432)

South-East Asia Regional Action Plan on Programmatic Management of Latent Tuberculosis Infection

World Health Organization (WHO), Regional Office for South-East Asia (2020) C_WHO

Download (206)

View PDF (391)

Pediatric oncology nursing practice in Latin America and the Caribbean

Pan American Health Organisation PAHO (2024) C_WHO

One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance... more

Download (418)

View PDF (639)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more